Industry Presentations

Treatment Option for CML


  • NON

    A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy

    Speakers:Jorge Cortes, MD

    Duration: 50 minutes

    Presented on: January 19, 2021

    *This session is not eligible for AMA PRA Category 1 CreditsTM